SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
This is a clear disclosure of shareholder vote results from the Combined 2025/2026 Annual Meeting of Stockholders held on June 29, 2026. The filing reports the final voting results for Proposal 1 (ratification of Macias Gini & O'Connell LLP as independent auditor), with 30,351,203 votes for, 400 against, and 5 abstentions, resulting in approval. This is a routine but material shareholder vote disclosure required under Item 5.07.
View raw filing on EDGAR →This document is the minute of an extraordinary general meeting held on June 30, 2026, disclosing shareholder voting results on five agenda items: (a) ratification of PricewaterhouseCoopers as appraiser; (b) approval of the appraisal report for Esfera Fidelidade S.A.; (c) approval of the merger protocol; (d) approval of the merger of Esfera into Banco Santander (Brasil); and (e) authorization of management acts. The document provides detailed vote tallies (favorable, opposing, and abstaining votes) for each resolution, which is the hallmark of shareholder_vote_results. The merger approval is material to investors as it represents a significant corporate transaction.
View raw filing on EDGAR →American Shared Hospital Services held its Annual Meeting on June 24, 2026, with shareholders voting on four proposals: election of four directors, an advisory vote on executive compensation, approval of an Amendment and Restatement of the Incentive Compensation Plan, and ratification of Baker Tilly US, LLP as independent auditor. The filing discloses the final voting results and outcomes for all proposals.
View raw filing on EDGAR →Skillsoft held its Annual Meeting on June 25, 2026, with 83.29% of outstanding shares present. Shareholders voted on and approved four proposals: election of three Class II directors (Michael S. Klein, Denis Nikolaev, and Arthur Gilliland), advisory approval of named executive officer compensation, approval of the Second Amendment to the 2020 Omnibus Incentive Plan (increasing the share pool by 550,000 shares), and ratification of Ernst & Young LLP as independent auditor.
View raw filing on EDGAR →Cloudflare held its Annual Meeting of stockholders on June 30, 2026, with voting results on seven major proposals: election of three Class I directors (Michelle Zatlyn, Scott Sandell, Karim Lakhani), ratification of KPMG LLP as independent auditor, advisory approval of named executive officer compensation, approval of amendments to the certificate of incorporation (establishing Class C common stock, increasing authorized shares, implementing a Class C split, and requiring independent director approval for certain acquisitions), and approval of amendments to the 2019 Equity Incentive Plan and Employee Stock Purchase Plan. All proposals passed with substantial majorities.
View raw filing on EDGAR →The 6-K discloses results of a General Meeting held on June 30, 2026, where shareholders voted on three proposals: (1) approval of a share consolidation at a ratio between 1-for-4 and 1-for-30, (2) amendment of the memorandum and articles of association to reflect the consolidation, and (3) an adjournment proposal. All three proposals passed with overwhelming majorities (99.81%, 99.88%, and 99.92% respectively). This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, and the share consolidation is material to investors as it affects share structure and voting rights.
View raw filing on EDGAR →The filing discloses results of RenovoRx's 2026 annual meeting of stockholders held on June 30, 2026, under Item 5.07. The company reports voting outcomes for three proposals: director elections (six directors elected), approval of a 2021 Plan amendment adding 2,000,000 shares (4.4% of outstanding shares), and ratification of Frank, Rimerman + Co. LLP as independent auditor. These are standard shareholder vote results that materially affect governance and equity structure.
View raw filing on EDGAR →This Item 5.07 disclosure reports the complete voting results from Blink Charging's June 30, 2026 Annual Meeting of Stockholders, including four proposals: election of four directors, approval of a 10,000,000-share increase to the 2018 Incentive Compensation Plan, advisory say-on-pay vote, and ratification of Grant Thornton LLP as independent auditor. The filing presents detailed vote tallies (For, Against, Abstained, Broker Non-Votes) for each proposal, which is the core content of a shareholder vote results disclosure under Item 5.07.
View raw filing on EDGAR →The filing discloses Item 5.07 results from Kairos Pharma's June 29, 2026 annual meeting of stockholders, including voting outcomes on five proposals: election of four directors, ratification of auditors (Weinberg & Company, P.A.), approval of a reverse stock split amendment (1:3 to 1:250 ratio at Board discretion), advisory approval of executive compensation, and approval of amendments to the 2023 Equity Incentive Plan (5M additional shares plus 5% evergreen provision). These results are material to investors as they reflect shareholder decisions on governance, capital structure, and equity incentives.
View raw filing on EDGAR →Workhorse Group held its Annual Meeting of Stockholders on June 29, 2026, with shareholders voting on four proposals: election of seven directors, a say-on-pay advisory vote, ratification of the independent auditor, and approval of an amended and restated long-term incentive plan. All four proposals passed with substantial majorities.
View raw filing on EDGAR →This Item 5.07 discloses the results of a stockholder vote (executed via written consent on June 26, 2026) approving an amendment and restatement of the Company's Certificate of Incorporation. The vote involved a majority of voting power across both Class A and Class B Common Stock, and the charter amendments include material changes to voting rights (reclassification of Class B shares and one-vote-per-share provisions) and governance structure. This is a classic shareholder vote result disclosure under Item 5.07.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from Snowflake's 2026 Annual Meeting held on June 29, 2026. The filing reports final voting tallies for four proposals: election of Class III directors (Teresa Briggs, Mark D. McLaughlin, and Sridhar Ramaswamy), a non-binding advisory vote on named executive officer compensation (which notably did not pass), ratification of PricewaterhouseCoopers LLP as independent auditor, and a stockholder proposal on majority voting for director elections. The rejection of the say-on-pay proposal is material to investors assessing governance and compensation practices.
View raw filing on EDGAR →Vivani held its Annual Meeting on June 24, 2026, with stockholders voting on and approving four proposals: election of six directors, advisory vote on named executive officer compensation, adoption of the 2022 Amended Plan, and ratification of BPM LLP as independent auditor. All proposals passed with substantial majorities.
View raw filing on EDGAR →Shareholders of SU Group Holdings Ltd voted on 25 June 2026 to approve a capital reorganisation involving reduction of par value from HK$0.10 to HK$0.000001 per share and a 100,000-for-1 share subdivision, and to adopt amended memorandum and articles of association. The Inspector of Election report documents the voting results on these material governance and capital structure changes.
View raw filing on EDGAR →This Item 5.07 disclosure presents the complete voting results from Archer Aviation's June 26, 2026 Annual Meeting of Stockholders, including four proposals: election of directors (Pilarski and Pinelli), redomestication from Delaware to Texas (failed), ratification of PwC as auditor (approved), and advisory vote on named executive officer compensation (approved). The filing directly satisfies the Item 5.07 requirement to disclose shareholder vote results with vote tallies and broker non-votes for each proposal.
View raw filing on EDGAR →Vivakor held its annual meeting of stockholders on June 30, 2026, with shareholders voting on nine proposals including election of four directors, approval of multiple stock issuances, a reverse stock split, auditor ratification, advisory compensation vote, and plan amendment. All proposals passed with substantial majorities.
View raw filing on EDGAR →Shareholders voted at the 2026 Annual Meeting of Stockholders held on June 25, 2026, approving the election of five director nominees to the board and ratifying Deloitte & Touche LLP as the independent auditor.
View raw filing on EDGAR →The Company held its 2026 Annual Meeting of Stockholders on June 24, 2026, with shareholders voting on the election of seven directors to the board and the ratification of KPMG LLP as independent auditor, with detailed vote tallies reported for each nominee.
View raw filing on EDGAR →This Item 5.07 disclosure presents the final voting results from Apogee Enterprises' Annual Meeting of Shareholders held on June 24, 2026, covering four proposals: re-election of two Class I directors (Donald A. Nolan and Patricia K. Wagner), advisory approval of executive compensation, approval of an amended stock incentive plan increasing authorized shares, and ratification of Deloitte & Touche LLP as independent auditor. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the core disclosure required by Item 5.07.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Black Diamond Therapeutics' 2026 Annual Meeting held on June 26, 2026, filed under Item 5.07. The filing reports final voting tallies for four proposals: election of two Class III directors (Shannon Campbell and Kapil Dhingra), ratification of PricewaterhouseCoopers LLP as auditor, advisory approval of named executive officer compensation, and determination of voting frequency for future compensation advisory votes. The disclosure includes vote counts (FOR, AGAINST, ABSTAIN, BROKER NON-VOTES) for each proposal, making this a textbook shareholder_vote_results event.
View raw filing on EDGAR →United Therapeutics held its Annual Meeting of Shareholders on June 26, 2026, with shareholders voting on four matters: election of 11 directors, advisory vote on executive compensation, approval of the 2026 Stock Incentive Plan, and ratification of Ernst & Young LLP as independent auditor. The filing discloses the detailed vote tallies for each matter.
View raw filing on EDGAR →TopBuild stockholders voted on June 29, 2026 to approve the merger agreement with QXO, with approximately 78% of votes cast (65% of outstanding shares) voting in favor of the TopBuild Merger Proposal.
View raw filing on EDGAR →QXO and TopBuild stockholders voted on the proposed acquisition on June 29, 2026. QXO stockholders approved the issuance of QXO common stock as consideration (~99% in favor) and a charter amendment to increase authorized shares from 2 billion to 4 billion (~99.2% in favor); TopBuild stockholders approved the merger agreement (78% of votes cast, 65% of outstanding shares).
View raw filing on EDGAR →Versamet Royalties Corp held its Annual General and Special Meeting of Shareholders on June 29, 2026, with shareholders voting on and approving four matters: appointment of PricewaterhouseCoopers LLP as auditors, election of eight directors, approval of amendments to the company's articles, and approval of amendments to the omnibus equity incentive plan.
View raw filing on EDGAR →The 6-K discloses results of an Annual General Meeting of Shareholders held on June 29, 2026, where shareholders approved five resolutions: re-election of four directors (Gillon Beck, Jacob Berman, Tom Overwijn, and Kelli Roiter) and appointment of Ernst & Young LLP as auditor. This is a classic shareholder_vote_results disclosure reporting the outcomes of a formal shareholder vote at an annual meeting.
View raw filing on EDGAR →Stockholders approved six proposals at the Annual Meeting held on June 26, 2026, including election of two Class III directors (Arvind Kush and Dennis Berman), ratification of CohnReznick LLP as auditor, amendments to the Certificate of Incorporation and 2020 Equity Incentive Plan, and advisory votes on executive compensation and voting frequency.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of the 2026 Annual Meeting of Shareholders held on June 23, 2026. The filing presents detailed voting results for the election of eight directors and ratification of Weaver and Tidwell, L.L.P. as independent auditor, including vote counts (FOR, AGAINST, ABSTAIN, and broker non-votes) for each matter. Shareholder vote results are material to investors as they reflect governance outcomes and board composition.
View raw filing on EDGAR →The filing discloses the results of the 2026 annual meeting of stockholders held on June 26, 2026, which is the required Item 5.07 disclosure. Although the meeting failed to achieve quorum and was adjourned without conducting any business—including director elections and auditor ratification—this is still a shareholder vote result disclosure. The failure to achieve quorum and the resulting holdover director arrangement is material to investors as it affects board composition and governance continuity.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of Virginia National Bankshares' 2026 Annual Meeting of Shareholders held on June 25, 2026, including voting outcomes for three proposals: (1) election of 11 directors, (2) advisory approval of executive compensation, and (3) ratification of the independent auditor Yount, Hyde & Barbour, P.C. The filing presents detailed vote tallies (votes for, against, withheld, and broker non-votes) for each director nominee and proposal, which is the standard format for shareholder vote results disclosures under Item 5.07.
View raw filing on EDGAR →American Eagle Outfitters held its Annual Meeting of Stockholders on June 29, 2026, with stockholders voting on four proposals: election of Class I director Jay L. Schottenstein, ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, and approval of an amendment to the 2023 Stock Award and Incentive Plan. All four proposals passed with reported vote tallies.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of the 2026 Annual Meeting of Stockholders held on June 25, 2026. The filing presents voting results for two proposals: (1) election of Class III Directors (R. Nolan Townsend, Brenda Cooperstone, and Paula HJ Cholmondeley) and (2) ratification of KPMG LLP as the independent auditor. The tabulated vote counts (FOR, WITHHELD/AGAINST, BROKER NON-VOTE/ABSTAIN) are the hallmark of shareholder vote result disclosures.
View raw filing on EDGAR →IMMUNIC held its annual stockholder meeting and disclosed final voting results, including election of three Class III Directors (Michael Bonney, Thorvald Nagel, and Richard Rudick), approval of an amendment to the 2019 Omnibus Equity Incentive Plan increasing authorized shares by 6,000,000, and ratification of Baker Tilly as independent auditor.
View raw filing on EDGAR →The exhibit is a shareholder letter dated June 29, 2026, following the Company's Annual General Meeting on June 26, 2026. It explicitly references the AGM vote ("Your vote is not something we take for granted") and reports the Board's mandate and plans to expand independent director representation. While the letter also contains forward-looking strategic commentary, the core disclosure is the AGM outcome and the Board's response, which constitutes shareholder vote results under Item 5.07 equivalent for a foreign private issuer.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from AleAnna's June 26, 2026 Annual Meeting of Stockholders under Item 5.07. The filing reports the voting outcomes for two proposals: election of Class II directors (Curtis Hébert Jr. and William K. Dirks) and ratification of Deloitte & Touche LLP as independent auditor, with detailed vote tallies showing both proposals were approved. This is a routine but material governance disclosure required by Item 5.07.
View raw filing on EDGAR →The filing discloses results of the 2026 annual meeting of stockholders held on June 29, 2026, with detailed voting tallies for five proposals including director elections, auditor ratification, equity plan amendment, warrant issuance authorization, and reverse stock split approval. Item 5.07 explicitly presents voting results with vote counts for each proposal, which is the defining characteristic of shareholder_vote_results. The equity plan amendment and warrant issuance approvals are material governance and capital structure decisions requiring shareholder authorization.
View raw filing on EDGAR →This Item 5.07 filing discloses the results of an extraordinary general meeting of CEPT shareholders held on June 29, 2026, where shareholders voted on four major proposals including approval of a Business Combination Agreement with Securitize, Inc., the CEPT Merger, organizational documents for the post-merger entity (PubCo), and Nasdaq Rule 5635 compliance. All proposals received requisite shareholder approval, with Proposal 1 (Business Combination) receiving 12,432,037 votes for, 2,151,147 against, and 197,157 abstentions. The filing explicitly states that "In light of receipt of the requisite approvals by CEPT Shareholders described above, CEPT expects the Business Combination to be completed promptly," confirming this is a material shareholder vote result that clears the path for a transformative M&A transaction.
View raw filing on EDGAR →The 6-K discloses results of an Extraordinary General Meeting of Shareholders held on June 29, 2026, where shareholders approved four material resolutions: (1) acquisition of 80–100% of Psyga Bio Ltd. via private placement of shares and warrants; (2) private placement of up to $1.5M from specified investors; (3) increase of authorized share capital by 2.9B shares; and (4) appointment of auditors. This is a classic shareholder vote results disclosure under Item 5.07 equivalent, and the underlying transactions (M&A, dilutive issuance, auditor appointment) are material to investors.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from a reconvened annual meeting held on June 23, 2026. The filing reports the outcomes of two proposals: (1) election of Ronald J. Kramer and Leslie D. Michelson as Class III directors, with specific vote tallies (For/Against/Abstain), and (2) stockholder approval to authorize sales of Common Stock below net asset value, with detailed voting results. This directly matches the shareholder_vote_results event type and Item 5.07 disclosure requirement.
View raw filing on EDGAR →Western Uranium & Vanadium held its Annual General and Special Meeting of Shareholders on June 26, 2026, with shareholder approval of director re-elections (George Glasier, Bryan Murphy, Andrew Wilder, Michael Skutezky), reappointment of MNP LLP as auditor, and reapproval of the 2023 Incentive Stock Option Plan and 2023 Shareholder Rights Plan.
View raw filing on EDGAR →The filing discloses results of a special meeting of stockholders held on June 24, 2026, where three proposals were voted on and approved: (i) approval of issuance of shares upon exercise of restricted common stock purchase warrants from the February 2026 Private Placement; (ii) approval of issuance of shares upon conversion of Series B Convertible Preferred Stock; and (iii) authorization for the Board to effect a reverse stock split at a ratio between one-for-two and one-for-two hundred fifty. This is a classic Item 5.07 shareholder vote results disclosure with material implications for capital structure and dilution.
View raw filing on EDGAR →Quantum Computing Inc. held its Annual Meeting on June 24, 2026, with shareholders voting on five proposals: election of six directors, advisory vote on named executive officer compensation, ratification of independent auditor BPM LLP, approval of a Certificate of Incorporation amendment increasing authorized shares from 260 million to 460 million, and approval of an amendment to the 2022 Equity and Incentive Plan increasing authorized shares from 20 million to 30 million and modifying the evergreen provision.
View raw filing on EDGAR →The 6-K furnishes a consolidated synthetic remote voting map for an Extraordinary General Meeting held on June 30, 2026, disclosing voting results on six resolutions. The core resolutions (Items 1–5) concern approval of a merger of Esfera Fidelidade S.A. into Banco Santander (Brasil), including ratification of the appraiser (PricewaterhouseCoopers), approval of the appraisal report, and approval of the merger protocol and transaction itself. These are material M&A-related shareholder votes with overwhelming approval (59+ million votes for on common shares). The disclosure is a post-vote reporting of shareholder approval results, fitting the shareholder_vote_results category under Item 5.07 equivalent.
View raw filing on EDGAR →This Item 5.07 filing discloses the results of Niagen Bioscience's 2026 Annual Meeting of Stockholders, including voting outcomes for three proposals: election of eight directors, ratification of Crowe LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents vote tallies (For, Against, Abstain, and Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07 for shareholder vote results.
View raw filing on EDGAR →NRC Health held its Annual Meeting of Stockholders on June 23, 2026, with shareholders voting on six proposals: election of seven directors, ratification of KPMG LLP as auditor, an advisory vote on named executive officer compensation, and three amendments to the certificate of incorporation. The detailed voting results for each proposal are disclosed.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of the Company's Annual Meeting of Stockholders held on June 24, 2026, including voting outcomes on three proposals: election of five directors, advisory approval of named executive officer compensation, and ratification of PwC as independent auditor. The filing presents vote tallies (For, Against, Abstentions, Broker Non-Votes) for each proposal, confirming all three passed with substantial majorities. This is a textbook shareholder_vote_results disclosure.
View raw filing on EDGAR →The filing's primary content is Item 5.07, which discloses the results of the Annual Meeting of Stockholders held on June 26, 2026. The filing presents detailed voting results on five matters: election of nine directors, amendment to the 2022 Equity Incentive Plan, advisory vote on named executive officer compensation, and ratification of Deloitte & Touche as independent auditors. While Item 8.01 also discloses a 5% stock dividend declaration, the substantive focus and Item designation center on shareholder vote results, which is material to investors assessing governance and capital allocation decisions.
View raw filing on EDGAR →The 6-K discloses the results of Robot Consulting Co., Ltd.'s Annual General Meeting of Shareholders held on June 26, 2026, with detailed voting tallies for all four proposals (approval of financial statements, election of statutory auditor, capital reduction and surplus disposition, and articles amendment). This is a classic shareholder_vote_results disclosure. The materiality is high because the proposals include capital reduction and articles amendment, which are structural changes affecting shareholders' interests.
View raw filing on EDGAR →This 8-K discloses Item 5.07 results from Orion S.A.'s Annual General Meeting of Shareholders held on June 25, 2026. The filing presents detailed voting results on 11 proposals, including director elections (Proposals 1(i)–1(viii)), board compensation approval (Proposal 2), say-on-pay votes (Proposals 3–4), financial statement approvals (Proposals 5–6), dividend allocation (Proposal 7), board and auditor discharge (Proposals 8–9), and auditor appointments (Proposals 10–11). All matters were approved by shareholders, making this a standard shareholder vote results disclosure material to investors' understanding of governance and capital allocation decisions.
View raw filing on EDGAR →The filing discloses Item 5.07 — submission of matters to a vote of security holders. On June 24, 2026, majority stockholders (collectively holding 95.3% of voting power) delivered written consent approving an amendment to the Company's Certificate of Incorporation to eliminate voting rights of Class E Common Stock except as required by law. This is a material shareholder action that fundamentally alters the capital structure and voting rights of the Company's security holders.
View raw filing on EDGAR →The filing discloses results of a special stockholder meeting held on June 26, 2026, where shareholders voted to approve two Warrant Inducement Agreements dated March 15, 2026 and April 26, 2026. Item 5.07 explicitly presents voting tallies (FOR, AGAINST, ABSTAIN) for both proposals, with both warrant agreements approved by substantial majorities. The approval satisfies the stockholder approval condition required under Nasdaq listing rules, permitting exercise of the new Series A-5 and Series A-6 warrants, which is material to investors assessing potential dilution and capital structure changes.
View raw filing on EDGAR →